Roles of Early Mobilization Program in Preventing Muscle Weakness and Decreasing Psychiatric Disorders in Patients with Coronavirus Disease 2019 Pneumonia: A Retrospective Observational Cohort Study.

acute respiratory failure coronavirus disease 2019 postintensive care syndrome

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
30 Jun 2021
Historique:
received: 31 05 2021
revised: 23 06 2021
accepted: 28 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

Although many coronavirus 2019 patients have experienced persistent symptoms and a long-term decline in quality of life after discharge, the details of these persistent symptoms and the effect of early rehabilitation are still unclear. We conducted a single-center, retrospective observational study to investigate the prevalence of persistent symptoms three months after discharge from the intensive care unit by checking the medical records. All patients received an early mobilization program. Four out of 13 patients (31%) had postintensive care syndrome. No patients had muscle weakness, and 11 patients (85%) returned to their previous work. However, psychiatric disorder, such as anxiety (23%) and posttraumatic stress disorder (15%), were observed. Eleven patients claimed persistent symptoms, including fatigue and numbness in the extremities. Our results suggest that the implementation of an early rehabilitation program plays some role in preventing muscle weakness and that decreasing psychiatric disorders should be a next target of patient care in the intensive care unit.

Identifiants

pubmed: 34209010
pii: jcm10132941
doi: 10.3390/jcm10132941
pmc: PMC8267911
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet. 2009 May 30;373(9678):1874-82
pubmed: 19446324
Am J Phys Med Rehabil. 2020 Dec;99(12):1092-1095
pubmed: 33002914
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Lancet Respir Med. 2021 Mar;9(3):239-250
pubmed: 33428871
Lancet Respir Med. 2020 Nov;8(11):1071-1073
pubmed: 33058770
Crit Care Med. 2008 Aug;36(8):2238-43
pubmed: 18596631
Crit Care Med. 2016 May;44(5):954-65
pubmed: 26807686
Crit Care Med. 2015 Mar;43(3):642-53
pubmed: 25513784
JAMA Netw Open. 2021 Feb 1;4(2):e210830
pubmed: 33606031
J Intensive Care. 2016 Aug 11;4:56
pubmed: 27525106
Chest. 2021 Jan;159(1):215-218
pubmed: 32835708
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Phys Ther. 2020 Jul 19;100(7):1062-1073
pubmed: 32280993
Crit Care. 2021 Feb 16;25(1):69
pubmed: 33593406
Crit Care Med. 2018 Dec;46(12):1914-1922
pubmed: 30119073
Crit Care Med. 2012 Feb;40(2):502-9
pubmed: 21946660
Crit Care Explor. 2021 Mar 12;3(3):e0353
pubmed: 33786432

Auteurs

Toru Kotani (T)

Department of Intensive Care Medicine, Showa University School of Medicine, Tokyo 142-8666, Japan.

Mizuki Sugiyama (M)

Department of Rehabilitation Medicine, Showa University School of Medicine, Tokyo 142-8666, Japan.

Fumika Matsuzaki (F)

Rehabilitation Center, Showa University Hospital, Tokyo 142-8666, Japan.

Kota Kubodera (K)

Rehabilitation Center, Showa University Hospital, Tokyo 142-8666, Japan.

Jin Saito (J)

Graduate School of Nursing and Rehabilitation Sciences, Showa University, Yokohama 226-8555, Japan.

Mika Kaneki (M)

Department of Nutrition, Showa University Hospital, Tokyo 142-8666, Japan.

Atsuko Shono (A)

Department of Intensive Care Medicine, Showa University School of Medicine, Tokyo 142-8666, Japan.

Hiroko Maruo (H)

Department of Intensive Care Medicine, Showa University School of Medicine, Tokyo 142-8666, Japan.

Maiko Mori (M)

Department of Intensive Care Medicine, Showa University School of Medicine, Tokyo 142-8666, Japan.

Shin Ohta (S)

Department of Internal Medicine, Showa University School of Medicine, Tokyo 142-8666, Japan.

Fumihito Kasai (F)

Department of Rehabilitation Medicine, Showa University School of Medicine, Tokyo 142-8666, Japan.

Classifications MeSH